keyword
https://read.qxmd.com/read/38601815/long-term-safety-of-tenapanor-in-people-with-irritable-bowel-syndrome-with-constipation-from-the-t3mpo-3-study-plain-language-summary-of-publication
#1
JOURNAL ARTICLE
Anthony J Lembo, Susan Edelstein, David P Rosenbaum, Ceciel Rooker, Jeffrey D Roberts, William D Chey
No abstract text is available yet for this article.
2024: Therapeutic Advances in Gastroenterology
https://read.qxmd.com/read/38558295/prevalence-and-determinants-of-postprandial-diarrhea-in-a-tertiary-care-center
#2
JOURNAL ARTICLE
Rafla Hassan, Prashant Singh, Sarah Ballou, Vikram Rangan, Johanna Iturrino, Jesse Katon, Anthony Lembo, Judy Nee
BACKGROUND AND AIMS: Postprandial diarrhea (PPD) is commonly seen in patients with disorders of gut-brain interaction (DGBI), but the factors associated with it have not been well studied. In this study, we aim to study the burden, impact, and predictors of PPD using a clinical cohort of DGBI patients. METHODS: This study included patients with chronic diarrhea fulfilling ROME IV criteria for irritable bowel syndrome (IBS) or functional diarrhea (FDiarr). PPD was defined as patients reporting mushy/watery stools following meals ≥30% of the time in the last 3 months using a ROME IV question on PPD...
April 1, 2024: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
https://read.qxmd.com/read/38528210/colonoscopy-utilization-in-elderly-patients-with-dementia-characteristics-complications-and-charges-in-a-national-matched-cohort-analysis
#3
JOURNAL ARTICLE
Faris Shweikeh, Gordon Hong, Kathleen Rogers, Mohamad Mouchli, Matthew Hoscheit, Anthony Lembo
BACKGROUND: It is projected that the elderly population will continue to increase. Many will develop chronic conditions such as dementia. AIMS: Our aims are to describe the utilization of colonoscopy among patients with dementia and compare outcomes in those with and without dementia. METHODS: This population-based analysis utilized the National Inpatient Sample (NIS) during 2019. Patients with dementia over the age of 60 years receiving colonoscopy were identified utilizing ICD-10 codes...
March 25, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38513981/endometriosis-is-associated-with-higher-healthcare-utilization-and-upper-gastrointestinal-symptoms
#4
JOURNAL ARTICLE
Madison Simons, Michael Cline, Ashley Gubbels, Cara King, Anthony Lembo, Stephen Lupe
No abstract text is available yet for this article.
March 19, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38380940/regional-practice-variation-and-outcomes-in-the-standard-versus-accelerated-initiation-of-renal-replacement-therapy-in-acute-kidney-injury-starrt-aki-trial-a-post-hoc-secondary-analysis
#5
JOURNAL ARTICLE
Suvi T Vaara, Ary Serpa Neto, Rinaldo Bellomo, Neill K J Adhikari, Didier Dreyfuss, Martin Gallagher, Stephane Gaudry, Eric Hoste, Michael Joannidis, Ville Pettilä, Amanda Y Wang, Kianoush Kashani, Ron Wald, Sean M Bagshaw, Marlies Ostermann
OBJECTIVES: Among patients with severe acute kidney injury (AKI) admitted to the ICU in high-income countries, regional practice variations for fluid balance (FB) management, timing, and choice of renal replacement therapy (RRT) modality may be significant. DESIGN: Secondary post hoc analysis of the STandard vs. Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial (ClinicalTrials.gov number NCT02568722). SETTING: One hundred-fifty-three ICUs in 13 countries...
February 2024: Critical care explorations
https://read.qxmd.com/read/38357940/clinical-outcomes-before-and-after-prucalopride-treatment-an-observational-study-in-patients-with-chronic-idiopathic-constipation-in-the-usa
#6
JOURNAL ARTICLE
Anthony Lembo, Brooks D Cash, Mei Lu, Emi Terasawa, Brian Terreri, Shawn Du, Rajeev Ayyagari, Paul Feuerstadt, Baharak Moshiree, Ben Westermeyer, Selina Pi, Mena Boules
INTRODUCTION: This real-world US-based claims study compared constipation-related symptoms and complications 6 months before and after prucalopride initiation in adults with chronic idiopathic constipation (CIC). METHODS: This observational, retrospective cohort analysis used the IBM MarketScan® Commercial Claims and Encounters and the Medicare Supplemental databases (January 2015-June 2020). Prucalopride-treated patients (≥18 years old) who had ≥1 constipation-related International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis code during the baseline or study period were included...
February 15, 2024: Clinical and Translational Gastroenterology
https://read.qxmd.com/read/38294158/abdominal-symptom-improvement-during-clinical-trials-of-tenapanor-in-patients-with-irritable-bowel-syndrome-with-constipation-a-post-hoc-analysis
#7
JOURNAL ARTICLE
Anthony J Lembo, William D Chey, Lucinda A Harris, Rosita Frazier, Darren M Brenner, Lin Chang, Brian E Lacy, Susan Edelstein, Yang Yang, Suling Zhao, David P Rosenbaum
INTRODUCTION: This post hoc analysis evaluated the efficacy of tenapanor on abdominal symptoms in patients with irritable bowel syndrome with constipation. Abdominal symptoms assessed included pain, discomfort, bloating, cramping, and fullness. METHODS: The abdominal symptom data were pooled from 3 randomized controlled trials (NCT01923428, T3MPO-1 [NCT02621892], and T3MPO-2 [NCT02686138]). Weekly scores were calculated for each abdominal symptom, and the Abdominal Score (AS) was derived as the average of weekly scores for abdominal pain, discomfort, and bloating...
March 15, 2024: American Journal of Gastroenterology
https://read.qxmd.com/read/38278192/burden-and-treatment-of-chronic-upper-gi-symptoms-and-diagnoses-a-nationwide-study
#8
JOURNAL ARTICLE
Ava M Sanayei, Chen Mo, Sarah Ballou, Nicole McHenry, Vikram Rangan, Prashant Singh, Johanna Iturrino, Anthony Lembo, Judy Nee
BACKGROUND & AIMS: Chronic gastrointestinal (GI) symptoms are a common reason for seeking medical care. We aim to determine the rates of ambulatory care use and to characterize demographics, work-up, and treatment (pharmacologic and nonpharmacologic) for patients with chronic upper GI symptoms and conditions in the United States. METHODS: Estimates of annual visits for the most common upper GI symptoms and diagnoses including gastroesophageal reflux disease, dyspepsia, nausea and vomiting, and gastroparesis were recorded from the 2007-2015 National Ambulatory Medical Care Surveys...
January 24, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38237696/the-efficacy-of-tradipitant-in-patients-with-diabetic-and-idiopathic-gastroparesis-in-a-phase-3-randomized-placebo-controlled-clinical-trial
#9
JOURNAL ARTICLE
Jesse L Carlin, Christos Polymeropoulos, Michael Camilleri, Anthony Lembo, Michaela Fisher, Caleigh Kupersmith, Darby Madonick, Paula Moszczynski, Sandra Smieszek, Changfu Xiao, Gunther Birznieks, Mihael H Polymeropoulos
BACKGROUND: Neurokinin receptor 1 antagonists are effective in reducing nausea and vomiting in chemotherapy-induced emesis. We investigated the safety and efficacy of tradipitant, a neurokinin receptor 1 antagonist, in patients with idiopathic and diabetic gastroparesis. METHODS: A total of 201 adults with gastroparesis were randomly assigned to oral tradipitant 85 mg (n = 102) or placebo (n = 99) twice daily for 12 weeks. Symptoms were assessed by a daily symptom dairy, Gastroparesis Cardinal Symptom Index scores, and other patient-reported questionnaires...
January 17, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38224609/how-would-you-manage-this-patient-with-recurrent-diverticulitis
#10
LETTER
Judy W Nee, Anthony J Lembo
No abstract text is available yet for this article.
January 2024: Annals of Internal Medicine
https://read.qxmd.com/read/37706185/understanding-the-current-approaches-in-the-management-of-ibs-c-a-case-study
#11
JOURNAL ARTICLE
Anthony J Lembo
No abstract text is available yet for this article.
June 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/37668173/long-term-safety-of-tenapanor-in-patients-with-irritable-bowel-syndrome-with-constipation-in-the-t3mpo-3-study
#12
JOURNAL ARTICLE
Anthony J Lembo, Keith A Friedenberg, Ronald P Fogel, Susan Edelstein, Suling Zhao, Yang Yang, David P Rosenbaum, William D Chey
BACKGROUND: Tenapanor, a first-in-class, minimally systemic inhibitor of intestinal sodium/hydrogen exchanger isoform 3 (NHE3), is approved for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults based on two randomized, placebo-controlled, phase III studies (T3MPO-1 [NCT02621892], T3MPO-2 [NCT02686138]). The open-label T3MPO-3 extension study (NCT02727751) enrolled patients who completed these studies to investigate long-term safety and tolerability of tenapanor...
November 2023: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
https://read.qxmd.com/read/37315866/prevalence-and-associated-factors-of-bloating-results-from-the-rome-foundation-global-epidemiology-study
#13
JOURNAL ARTICLE
Sarah Ballou, Prashant Singh, Judy Nee, Vikram Rangan, Johanna Iturrino, Grace Geeganage, Bernd Löwe, Shrikant I Bangdiwala, Olafur S Palsson, Ami D Sperber, Anthony Lembo, Marco Lehmann
BACKGROUND & AIMS: Bloating is a common symptom in the general population and among disorders of gut-brain interaction, although its prevalence has not been well characterized. The aim of this study was to report the prevalence of bloating as a symptom in the worldwide population and to identify factors associated with this symptom in the general population. METHODS: Rome Foundation Global Epidemiology Study internet survey data were analyzed. After excluding respondents with potential organic causes of bowel symptoms, the current analysis included 51,425 individuals in 26 countries...
June 13, 2023: Gastroenterology
https://read.qxmd.com/read/37307586/how-would-you-manage-this-patient-with-recurrent-diverticulitis-grand-rounds-discussion-from-beth-israel-deaconess-medical-center
#14
JOURNAL ARTICLE
Howard Libman, Judy W Nee, Anthony J Lembo, Risa B Burns
Acute diverticulitis, which refers to inflammation or infection, or both, of a colonic diverticulum, is a common medical condition that may occur repeatedly in some persons. It most often manifests with left-sided abdominal pain, which may be associated with low-grade fever and other gastrointestinal symptoms. Complications may include abscess, fistula formation, perforation, and bowel obstruction. The American College of Physicians recently published practice guidelines on the diagnosis and management of acute diverticulitis, the role of colonoscopy after resolution, and interventions to prevent recurrence of this condition...
June 2023: Annals of Internal Medicine
https://read.qxmd.com/read/37227428/integrating-contact-tracing-and-whole-genome-sequencing-to-track-the-elimination-of-dog-mediated-rabies-an-observational-and-genomic-study
#15
JOURNAL ARTICLE
Kennedy Lushasi, Kirstyn Brunker, Malavika Rajeev, Elaine A Ferguson, Gurdeep Jaswant, Laurie Louise Baker, Roman Biek, Joel Changalucha, Sarah Cleaveland, Anna Czupryna, Anthony R Fooks, Nicodemus J Govella, Daniel T Haydon, Paul C D Johnson, Rudovick Kazwala, Tiziana Lembo, Denise Marston, Msanif Masoud, Matthew Maziku, Eberhard Mbunda, Geofrey Mchau, Ally Z Mohamed, Emmanuel Mpolya, Chanasa Ngeleja, Kija Ng'habi, Hezron Nonga, Kassim Omar, Kristyna Rysava, Maganga Sambo, Lwitiko Sikana, Rachel Steenson, Katie Hampson
BACKGROUND: Dog-mediated rabies is endemic across Africa causing thousands of human deaths annually. A One Health approach to rabies is advocated, comprising emergency post-exposure vaccination of bite victims and mass dog vaccination to break the transmission cycle. However, the impacts and cost-effectiveness of these components are difficult to disentangle. METHODS: We combined contact tracing with whole-genome sequencing to track rabies transmission in the animal reservoir and spillover risk to humans from 2010-2020, investigating how the components of a One Health approach reduced the disease burden and eliminated rabies from Pemba Island, Tanzania...
May 25, 2023: ELife
https://read.qxmd.com/read/37211380/american-gastroenterological-association-american-college-of-gastroenterology-clinical-practice-guideline-pharmacological-management-of-chronic-idiopathic-constipation
#16
JOURNAL ARTICLE
Lin Chang, William D Chey, Aamer Imdad, Christopher V Almario, Adil E Bharucha, Susan Diem, Katarina B Greer, Brian Hanson, Lucinda A Harris, Cynthia Ko, M Hassan Murad, Amit Patel, Eric D Shah, Anthony J Lembo, Shahnaz Sultan
INTRODUCTION: Chronic idiopathic constipation (CIC) is a common disorder associated with significant impairment in quality of life. This clinical practice guideline, jointly developed by the American Gastroenterological Association and the American College of Gastroenterology, aims to inform clinicians and patients by providing evidence-based practice recommendations for the pharmacological treatment of CIC in adults. METHODS: The American Gastroenterological Association and the American College of Gastroenterology formed a multidisciplinary guideline panel that conducted systematic reviews of the following agents: fiber, osmotic laxatives (polyethylene glycol, magnesium oxide, lactulose), stimulant laxatives (bisacodyl, sodium picosulfate, senna), secretagogues (lubiprostone, linaclotide, plecanatide), and serotonin type 4 agonist (prucalopride)...
June 2023: Gastroenterology
https://read.qxmd.com/read/37204227/american-gastroenterological-association-american-college-of-gastroenterology-clinical-practice-guideline-pharmacological-management-of-chronic-idiopathic-constipation
#17
JOURNAL ARTICLE
Lin Chang, William D Chey, Aamer Imdad, Christopher V Almario, Adil E Bharucha, Susan Diem, Katarina B Greer, Brian Hanson, Lucinda A Harris, Cynthia Ko, M Hassan Murad, Amit Patel, Eric D Shah, Anthony J Lembo, Shahnaz Sultan
INTRODUCTION: Chronic idiopathic constipation (CIC) is a common disorder associated with significant impairment in quality of life. This clinical practice guideline, jointly developed by the American Gastroenterological Association and the American College of Gastroenterology, aims to inform clinicians and patients by providing evidence-based practice recommendations for the pharmacological treatment of CIC in adults. METHODS: The American Gastroenterological Association and the American College of Gastroenterology formed a multidisciplinary guideline panel that conducted systematic reviews of the following agents: fiber, osmotic laxatives (polyethylene glycol, magnesium oxide, lactulose), stimulant laxatives (bisacodyl, sodium picosulfate, senna), secretagogues (lubiprostone, linaclotide, plecanatide), and serotonin type 4 agonist (prucalopride)...
June 1, 2023: American Journal of Gastroenterology
https://read.qxmd.com/read/37099779/racial-and-ethnic-disparities-in-opioid-prescriptions-in-benign-and-malignant-pancreatic-disease-in-the-united-states
#18
JOURNAL ARTICLE
Nicole McHenry, Awais Ahmed, Ishani Shah, Steven D Freedman, Judy Nee, Anthony Lembo, Sunil G Sheth
OBJECTIVES: Racial-ethnic disparities in pain management are common but not known among pancreatic disease patients. We sought to evaluate racial-ethnic disparities in opioid prescriptions for pancreatitis and pancreatic cancer patients. METHODS: Data from the National Ambulatory Medical Care Survey were used to examine racial-ethnic and sex differences in opioid prescriptions for ambulatory visits by adult pancreatic disease patients. RESULTS: We identified 207 pancreatitis and 196 pancreatic cancer patient visits, representing 9...
November 2022: Pancreas
https://read.qxmd.com/read/37053553/what-is-unspecified-functional-bowel-disorder-a-commonly-seen-rarely-recognized-and-poorly-understood-diagnosis
#19
JOURNAL ARTICLE
Sarah Ballou, Vikram Rangan, Andrew Eidelberg, Samantha Proctor, Nicole McHenry, Judy Nee, Johanna Iturrino, Anthony Lembo, Prashant Singh
INTRODUCTION: Unspecified functional bowel disorder (FBD-U) is a Rome IV diagnosis of exclusion and occurs when patients report bowel symptoms but do not meet the criteria for other functional bowel disorders (FBD; irritable bowel syndrome [IBS], functional constipation [FC], functional diarrhea [FDr], or functional bloating). Previous research suggests that FBD-U is as/more common than IBS. METHODS: One thousand five hundred one patients at a single-center tertiary care center completed an electronic survey...
August 1, 2023: American Journal of Gastroenterology
https://read.qxmd.com/read/36822371/randomized-placebo-controlled-phase-3-trial-of-vibrating-capsule-for-chronic-constipation
#20
RANDOMIZED CONTROLLED TRIAL
Satish S C Rao, Eamonn M M Quigley, William D Chey, Amol Sharma, Anthony J Lembo
BACKGROUND & AIMS: Despite therapeutic advances, effective treatments for chronic constipation remain an unmet need. The vibrating capsule is a nonpharmacologic, orally ingested, programmable capsule that vibrates intraluminally to induce bowel movements. We aimed to determine the efficacy and safety of the vibrating capsule in patients with chronic constipation. METHODS: We conducted a phase 3, double-blind, placebo-controlled trial of patients with chronic constipation, who were randomized to receive either a vibrating or placebo capsule, once daily, 5 days a week for 8 weeks...
June 2023: Gastroenterology
keyword
keyword
111045
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.